Foulkes Caio, Friedrich Nikolas, Ivan Branislav, Stiegeler Emanuel, Magnus Carsten, Schmidt Daniel, Karakus Umut, Weber Jacqueline, Günthard Huldrych F, Pasin Chloé, Rusert Peter, Trkola Alexandra
Institute of Medical Virology, University of Zurich (UZH), Zurich, Switzerland.
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.
PLoS Pathog. 2025 Jan 21;21(1):e1012825. doi: 10.1371/journal.ppat.1012825. eCollection 2025 Jan.
For use in prevention and treatment, HIV-1 broadly neutralizing antibodies (bnAbs) have to overcome Env conformational heterogeneity of viral quasispecies and neutralize with constant high potency. Comparative analysis of neutralization data from the CATNAP database revealed a nuanced relationship between bnAb activity and Env conformational flexibility, with substantial epitope-specific variation of bnAb potency ranging from increased to decreased activity against open, neutralization-sensitive Env. To systematically investigate the impact of variability in Env conformation on bnAb potency we screened 126 JR-CSF point mutants for generalized neutralization sensitivity to weakly neutralizing antibodies (weak-nAbs) depending on trimer opening and plasma from people with chronic HIV-1 infection. 23 mutations resulted in a highly neutralization sensitive phenotype, which was associated with de-stabilization of the closed, prefusion conformation. Including 19 of these mutants into a Sensitivity Env mutant panel (SENSE-19), we classified bnAbs according to potency variations in response to trimer opening. To verify that these sensitivity patterns are independent of the in vitro assay system, replication-competent SENSE-19 mutant viruses were tested on primary CD4 T cells. While loss of potency on SENSE-19 was registered for bnAbs from several classes recognizing quaternary epitopes on pre-triggered Env, structural destabilization benefitted MPER bnAbs and other inhibitors known to have post-CD4 attachment neutralization activity. Importantly, for a subset of CD4bs bnAbs, and the interface bnAb PGT151, particularly low potency variation was noted, suggesting that Env conformational tolerance can be achieved but is not the rule. In summary, SENSE-19 screens revealed distinct tolerance levels to Env conformational intermediates between bnAbs that provide mechanistic insights in their function and broaden current neutralization breadth assessments.
为用于预防和治疗,HIV-1广泛中和抗体(bnAbs)必须克服病毒准种的Env构象异质性,并始终保持高效中和能力。对CATNAP数据库中的中和数据进行比较分析后发现,bnAb活性与Env构象灵活性之间存在细微差别,bnAb效力在表位特异性上有很大差异,对开放的、中和敏感的Env的活性从增加到降低不等。为了系统地研究Env构象变异性对bnAb效力的影响,我们筛选了126个JR-CSF点突变体,以检测其对弱中和抗体(弱nAbs)的广义中和敏感性,这取决于三聚体的开放情况以及慢性HIV-1感染者的血浆。23个突变导致了高度中和敏感的表型,这与封闭的、融合前构象的不稳定有关。将其中19个突变体纳入敏感性Env突变体库(SENSE-19),我们根据三聚体开放时的效力变化对bnAbs进行了分类。为了验证这些敏感性模式与体外检测系统无关,我们在原代CD4 T细胞上测试了具有复制能力的SENSE-19突变病毒。虽然几类识别预触发Env上四级表位的bnAbs在SENSE-19上的效力有所下降,但结构不稳定对MPER bnAbs和其他已知具有CD4后附着中和活性的抑制剂有利。重要的是,对于一部分CD4bs bnAbs以及界面bnAb PGT151,观察到其效力变化特别低,这表明可以实现Env构象耐受性,但并非普遍规律。总之,SENSE-19筛选揭示了bnAbs对Env构象中间体的不同耐受水平,这为其功能提供了机制性见解,并拓宽了当前的中和广度评估。